Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.36 |
| ▸ | FDPS | P14324 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18222653 | 1.00 | ALDH1A1 (0.54) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL8996397 | 0.95 | ALDH1A1 (0.47) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL6441220 | 0.95 | ALDH1A1 (0.59) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL7288108 | 0.95 | ALDH1A1 (0.59) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL236338 | 0.95 | ALDH1A1 (0.47) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL6445562 | 0.92 | LMNA (0.58) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL3090863 | 0.92 | SMN1; SMN2 (0.52) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL16548258 | 0.92 | SMN1; SMN2 (0.52) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL16896968 | 0.92 | SMN1; SMN2 (0.52) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 | |
| SCHEMBL3097319 | 0.90 | LMNA (0.62) | ALDH1A1LMNASMN1; SMN2TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10000432-B2 | Processes for the synthesis of chiral 1-alkanols | PURDUE RESEARCH FOUNDATION (US) | 2018-06-19 | — | — | US | disclosed |
| EP-3124551-A1 | RHODAMINE-BASED COLORING COMPOSITION | Wako Pure Chemical Industries, Ltd. (JP) | 2017-02-01 | — | — | EP | disclosed |
| US-20160332940-A1 | PROCESSES FOR THE SYNTHESIS OF CHIRAL 1-ALKANOLS | PURDUE RESEARCH FOUNDATION (US) | 2016-11-17 | — | — | US | disclosed |
| US-6888030-B2 | Advances in amination | HUNTSMAN PETROCHEMICAL CORPORATION (US) | 2005-05-03 | — | — | US | disclosed |
| US-20030078344-A1 | Advances in amination | HUNTSMAN PETROCHEMICAL CORPORATION | 2003-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160332940-A1 | PROCESSES FOR THE SYNTHESIS OF CHIRAL 1-ALKANOLS | CYP51A1, ALKBH3, ALKBH1 | ALDH1A1 500/4885LMNA 3812/4885SMN1; SMN2 4633/4885 |
| US-10000432-B2 | Processes for the synthesis of chiral 1-alkanols | CYP51A1, ALKBH3, ALKBH1 | ALDH1A1 500/4885LMNA 3812/4885SMN1; SMN2 4633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.